T. Rowe Price Associates’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52M Buy
46,311
+2,831
+7% +$92.8K ﹤0.01% 1775
2025
Q1
$1.4M Sell
43,480
-116
-0.3% -$3.74K ﹤0.01% 1775
2024
Q4
$1.33M Buy
43,596
+3,267
+8% +$99.9K ﹤0.01% 1838
2024
Q3
$1.13M Buy
40,329
+471
+1% +$13.2K ﹤0.01% 1923
2024
Q2
$908K Buy
39,858
+7,656
+24% +$174K ﹤0.01% 1940
2024
Q1
$980K Sell
32,202
-341,559
-91% -$10.4M ﹤0.01% 1926
2023
Q4
$13.3M Sell
373,761
-60,722
-14% -$2.17M ﹤0.01% 1038
2023
Q3
$19M Sell
434,483
-1,170
-0.3% -$51.3K ﹤0.01% 926
2023
Q2
$21.5M Buy
435,653
+203
+0% +$10K ﹤0.01% 918
2023
Q1
$18.1M Buy
435,450
+819
+0.2% +$33.9K ﹤0.01% 941
2022
Q4
$19.3M Buy
434,631
+2,551
+0.6% +$113K ﹤0.01% 919
2022
Q3
$16.9M Sell
432,080
-1,367,334
-76% -$53.5M ﹤0.01% 951
2022
Q2
$73.5M Sell
1,799,414
-84,857
-5% -$3.47M 0.01% 751
2022
Q1
$124M Sell
1,884,271
-61,480
-3% -$4.04M 0.01% 661
2021
Q4
$135M Sell
1,945,751
-70,745
-4% -$4.92M 0.01% 672
2021
Q3
$140M Sell
2,016,496
-155,097
-7% -$10.8M 0.01% 663
2021
Q2
$172M Sell
2,171,593
-94,035
-4% -$7.46M 0.02% 609
2021
Q1
$148M Sell
2,265,628
-65,805
-3% -$4.31M 0.01% 645
2020
Q4
$130M Buy
2,331,433
+113,794
+5% +$6.33M 0.01% 638
2020
Q3
$88.5M Sell
2,217,639
-11,207
-0.5% -$447K 0.01% 692
2020
Q2
$100M Buy
2,228,846
+454,992
+26% +$20.5M 0.01% 639
2020
Q1
$59.6M Sell
1,773,854
-32,745
-2% -$1.1M 0.01% 727
2019
Q4
$58.7M Buy
1,806,599
+3,425
+0.2% +$111K 0.01% 860
2019
Q3
$45M Buy
1,803,174
+111,682
+7% +$2.79M 0.01% 909
2019
Q2
$50.5M Sell
1,691,492
-491,016
-22% -$14.7M 0.01% 891
2019
Q1
$58.5M Buy
2,182,508
+2,175
+0.1% +$58.3K 0.01% 811
2018
Q4
$66.7M Sell
2,180,333
-34,358
-2% -$1.05M 0.01% 713
2018
Q3
$77.6M Sell
2,214,691
-175,176
-7% -$6.14M 0.01% 753
2018
Q2
$64.6M Buy
2,389,867
+898,494
+60% +$24.3M 0.01% 784
2018
Q1
$30.6M Buy
+1,491,373
New +$30.6M ﹤0.01% 1037